Citadel Advisors’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.1K | Sell |
|
|||||
|
2025
Q1 | $43.5K | Buy |
|
|||||
|
2024
Q4 | $60.7K | Buy |
|
|||||
|
2024
Q3 | $76.7K | Sell |
|
|||||
|
2024
Q2 | $460K | Buy |
|
|||||
|
2024
Q1 | $547K | Sell |
|
|||||
|
2023
Q4 | $428K | Sell |
|
|||||
|
2023
Q3 | $566K | Buy |
|
|||||
|
2023
Q2 | $708K | Sell |
|
|||||
|
2023
Q1 | $710K | Sell |
|
|||||
|
2022
Q4 | $736K | Buy |
|
|||||
|
2022
Q3 | $1.3M | Buy |
|
|||||
|
2022
Q2 | $1.85M | Buy |
|
|||||
|
2022
Q1 | $1.9M | Sell |
|
|||||
|
2021
Q4 | $2.36M | Sell |
|
|||||
|
2021
Q3 | $2.67M | Sell |
|
|||||
|
2021
Q2 | $5.71M | Sell |
|
|||||
|
2021
Q1 | $10.6M | Sell |
|
|||||
|
2020
Q4 | $11.7M | Sell |
|
|||||
|
2020
Q3 | $9.48M | Buy |
|
|||||
|
2020
Q2 | $1.17M | Sell |
|
|||||
|
2020
Q1 | $3.1M | Sell |
|
|||||
|
2019
Q4 | $44.9M | Sell |
|
|||||
|
2019
Q3 | $29M | Sell |
|
|||||
|
2019
Q2 | $16.4M | Buy |
|